Humer Franz B - Insider Non-Derivative Transactions at Allogene Therapeutics, Inc. (ALLO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 5, 2024, Humer Franz B's relationship to Allogene Therapeutics, Inc. (ALLO) is Director, and currently has 316,728 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ALLO insiders.
Data Source: SEC.
Humer Franz B - Insider Non-Derivative Transactions of ALLO Common Stock
Humer Franz B - Insider Non-Derivative Transactions at ALLO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 6, 2024 | Acquisition -- (Common Stock) | 61475 | 0 | 316728 |
| May 31, 2024 | Sell -- (Common Stock) | 11200 | 2.34 | 255253 |
| Jun 14, 2023 | Acquisition -- (Common Stock) | 74561 | 0 | 266453 |